APA (7th ed.) Citation

Falchook, G., Duvic, M., Hong, D., Wheler, J., Naing, A., Lim, J., & Kurzrock, R. (2012). Age-stratified phase I trial of a combination of bortezomib, gemcitabine, and liposomal doxorubicin in patients with advanced malignancies. Cancer Chemotherapy & Pharmacology, 69(5), 1117. https://doi.org/10.1007/s00280-011-1808-4

Chicago Style (17th ed.) Citation

Falchook, G., M. Duvic, D. Hong, J. Wheler, A. Naing, J. Lim, and R. Kurzrock. "Age-stratified Phase I Trial of a Combination of Bortezomib, Gemcitabine, and Liposomal Doxorubicin in Patients with Advanced Malignancies." Cancer Chemotherapy & Pharmacology 69, no. 5 (2012): 1117. https://doi.org/10.1007/s00280-011-1808-4.

MLA (9th ed.) Citation

Falchook, G., et al. "Age-stratified Phase I Trial of a Combination of Bortezomib, Gemcitabine, and Liposomal Doxorubicin in Patients with Advanced Malignancies." Cancer Chemotherapy & Pharmacology, vol. 69, no. 5, 2012, p. 1117, https://doi.org/10.1007/s00280-011-1808-4.